Research indicates that berberine may reduce brain injury associated with necrotizing enterocolitis by modulating the TLR4/MyD88/NF-κB/NLRP3 signaling pathway. This discovery could inform future therapeutic strategies for affected infants.
berberine attenuates necrotizing enterocolitis associated brain injury via the tlr4 myd88 nf b nlrp3 pathway
Original title: “[Berberine attenuates necrotizing enterocolitis-associated brain injury via the TLR4/MyD88/NF-κB/NLRP3 pathway].”